Table II.

Demographic and clinical details of study group

Age	Mean: 72.6 ±9.2 years (min: 61; max: 88)
Risk scores	CHA2DS2VASc 5 ±1.7 HAS-BLED 3.8 ±0.9
Gender	9 female 10 male
Type of atrial fibrillation	Paroxysmal, n = 13 (68.4%) Persistent, n = 6 (31.6%)
Contraindication for OAC	Bleeding, n = 16 (84.2%): – intracranial, n = 2 (10.5%) – gastrointestinal, n = 9 (47.4%) – eye vitreous body, n = 2 (10.5%) – urinary tract/pelvis, n = 2 (10.5%) – recurrent epistaxis, n = 1 (5.3%) Stroke on OAC/NOAC, n = 3 (15.8%)
Diabetes	n = 6 (31.6%)
Previous stroke	n = 10 (52.6%)
TAVI in the past	n = 2 (10.5%)